Amgen stays strong, AVI emerging from consolidation. Hear Bill and the committee’s take on these biotech names and what could happen next.

Segment begins with Bill Baruch at 2:28

Discover Blue Line Capital

Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.